Cariprazine versus risperidone monotherapy for treatment of predominant negative symptoms in patients with schizophrenia: a randomised, double-blind, controlled trial

Predictive Values of Neurocognition and Negative Symptoms on Functional Outcome in Schizophrenia: A Longitudinal First-Episode Study With 7-Year Follow-Up

P. Milev, Beng‐Choon Ho, Stephan Arndt et al. · American Journal of Psychiatry · 2005 · 930 citations

Medicine, Psychiatry, Psychology +17

Cariprazine (RGH-188), a Dopamine D3 Receptor-Preferring, D3/D2 Dopamine Receptor Antagonist–Partial Agonist Antipsychotic Candidate: In Vitro and Neurochemical Profile

Béla Kiss, Attila Horváth, Zsolt Némethy et al. · Journal of Pharmacology and Experimental Therapeutics · 2010 · 365 citations

Medicine, Medicinal Chemistry, Pharmacology +16

Treatment of Negative Symptoms in Schizophrenia with Amisulpride

P Boyer, Y. Lecrubier, A Puech et al. · The British Journal of Psychiatry · 1995 · 227 citations

Medicine, Pharmacology, Psychiatry +17

Amisulpride versus placebo in the medium-term treatment of the negative symptoms of schizophrenia

H. Lôo, M F Poirier-Littré, Michel Theron et al. · The British Journal of Psychiatry · 1997 · 193 citations

Medicine, Pharmacology, Pharmacotherapy +16

Improvement of Schizophrenic Patients With Primary Negative Symptoms Treated With Amisulpride

Jean‐Marie Danion, W. Rein, O. Fleurot et al. · American Journal of Psychiatry · 1999 · 184 citations

Medicine, Pharmacology, Psychiatry +17